Evidence map›Paper›PMID 34929358›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022

SARS-CoV-2 seroprevalence in Aden, Yemen: a population-based study.

Abdulla Salem Bin-Ghouth, Sheikh Al-Shoteri, Nuha Mahmoud, Altaf Musani, Nasser Mohsen Baoom, Ali Ahmed Al-Waleedi, Evans Buliva, Eman AbdelKreem Aly, Jeremias Domingos Naiene, Rosa Crestani and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Abdulla Salem Bin-GhouthCollege of Medicine, Hadhramout University, Mukalla, Yemen. Electronic address: abinghouth2007@yahoo.com.
Sheikh Al-ShoteriAden University, Yemen.
Nuha MahmoudWorld Health Organization Country Office, Yemen.
Altaf MusaniWorld Health Organization Country Office, Yemen.
Nasser Mohsen BaoomMinistry of Public Health and Population, Yemen.
Ali Ahmed Al-WaleediMinistry of Public Health and Population, Yemen.
Evans BulivaWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Eman AbdelKreem AlyWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Jeremias Domingos NaieneWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Rosa CrestaniWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Mikiko SengaWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Amal BarakatWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Lubna Al-AriqiWorld Health Organization Eastern Mediterranean Regional Office, Cairo, Egypt.
Khaled Zein Al-SakkafAden University, Yemen.
Abeer ShaefAden University, Yemen.
Najib ThabitWorld Health Organization Country Office, Yemen.
Ahmed MurshedWorld Health Organization Country Office, Yemen.
Samuel OmaraWorld Health Organization Country Office, Yemen.
World Health Organization Regional Office for the Eastern Mediterranean · EGUniversity of Aden · YEHadhramout University · YE

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundIn Yemen, initial surveillance of coronavirus disease 2019 (COVID-19) focused primarily on patients with symptoms or severe disease. The full spectrum of the disease remains unclear. To the best of the authors' knowledge, this is the first seroprevalence study performed in Yemen.

methodsThis cross-sectional investigation included 2001 participants from all age groups from four districts in Aden, southern Yemen. A multi-stage sampling method was used. Data were collected using a well-structured questionnaire, and blood samples were taken. Healgen COVID-19 IgG/IgM Rapid Diagnostic Test (RDT) Cassettes were used in all participants. All positive RDTs and 14% of negative RDTs underwent enzyme-linked immunosorbent assay (ELISA) testing (WANTAI SARS-CoV-2 Ab ELISA Kit) for confirmation.

resultsIn total, 549 of 2001 participants were RDT positive and confirmed by ELISA, giving a prevalence of COVID-19 of 27.4%. The prevalence of immunoglobulin G was 25%. The prevalence of asymptomatic COVID-19 in the entire study group was 7.9%. The highest prevalence was observed in Al-Mansurah district (33.4%). Regarding sociodemographic factors, the prevalence of COVID-19 was significantly higher among females, housewives and subjects with a history of contact with a COVID-19 patient: 32%, 31% and 39%, respectively.

conclusionThis study found high prevalence of COVID-19 in the study population. Household transmission was common.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralCross-Sectional StudiesDiagnostic Tests, RoutineFemaleHumansImmunoglobulin MSeroepidemiologic StudiesSociodemographic FactorsYemenAntibodies, ViralImmunoglobulin MAntibodiesCOVID-19 serosurveyELISAImmunitySARS-CoV-2 sero-epidemiology

Identifiers

PMID34929358
PMCPMC8677627
OpenAlexW4221063414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.